Elon Musk has taken to social media, unveiling his noticeable weight loss while donning a Santa Claus outfit for the holidays. Describing himself as ‘Ozempic Santa’, Musk’s transformation has raised eyebrows, especially considering the contrasting views on weight loss drugs shared by political figures.
In a recent photo shared on his platform X (formerly Twitter), Musk showcased his slimmer figure, particularly around his waist. He revealed that he is actually using a weight loss medication known as Mounjaro, rather than the more widely known Ozempic. Mounjaro requires a weekly non-insulin injection and is primarily intended for managing type 2 diabetes.
In his post, Musk highlighted the advantages of Mounjaro, stating, “Mounjaro seems to have fewer side effects and be more effective,” even though he admitted to trying Ozempic in the past. This disclosure comes at a time when the selection of Robert F. Kennedy Jr. as Trump’s Health Secretary has sparked a debate over the reliance on pharmaceutical solutions for weight management.
Kennedy has consistently advocated for lifestyle changes over medications, suggesting that improved diet and regular meals could combat obesity and diabetes more effectively than medication. He emphasized a return to healthier eating habits in his campaign to ‘Make America Healthy Again’.
Contrasting with Kennedy’s views, Musk has been vocal in his support for GLP (glucagon-like peptide) drugs like Mounjaro, stating they could significantly improve the health and longevity of Americans if made more affordable. This has painted a picture of a growing divide in public health rhetoric, particularly among key political figures.
Interestingly, Musk and Kennedy have both been seen together on social media with other Republican figures while seemingly indulging in fast food, emphasizing the complexity of their health messages. As this topic continues to develop, the discussions surrounding weight loss, health, and the role of medications remain more relevant than ever.
Source: Metro
